David T Huang
Overview
Explore the profile of David T Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
224
Citations
6438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rogers M, Harner A, Buhay M, Firek B, Methe B, Morris A, et al.
PLoS One
. 2025 Feb;
20(2):e0319276.
PMID: 39919088
[This corrects the article DOI: 10.1371/journal.pone.0290062.].
2.
Goldenberg I, Ezekowitz J, Albert C, Alexis J, Anderson L, Behr E, et al.
Heart Rhythm
. 2025 Feb;
PMID: 39918486
The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA). Current guidelines provide a recommendation to implant a prophylactic...
3.
Goldenberg I, Ezekowitz J, Albert C, Alexis J, Anderson L, Behr E, et al.
J Card Fail
. 2025 Feb;
PMID: 39915204
The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA). Current guidelines provide a recommendation to implant a prophylactic...
4.
Wang M, Goldenberg I, Younis A, Goldenberg I, Christof M, Huang D, et al.
Heart Rhythm
. 2024 Nov;
PMID: 39581430
Background: There are limited data on clinical and arrhythmic outcomes after a first ventricular tachyarrhythmia (VTA) in heart failure (HF) patients who receive a primary prevention implantable cardioverter-defibrillator (ICD). Objective:...
5.
Goldenberg I, Younis A, Huang D, Rosero S, Kutyifa V, McNitt S, et al.
J Cardiovasc Electrophysiol
. 2024 Nov;
36(1):188-197.
PMID: 39533482
Introduction: The implantable cardioverter defibrillator reduces mortality among patients with heart failure (HF) due to ischemic heart disease. Clinical trial data have called into question the benefit of an ICD...
6.
Godoy L, Neal M, Goligher E, Cushman M, Houston B, Bradbury C, et al.
JACC Adv
. 2024 Jun;
3(3):100780.
PMID: 38938844
Background: Clinical trials suggest that therapeutic-dose heparin may prevent critical illness and vascular complications due to COVID-19, but knowledge gaps exist regarding the efficacy of therapeutic heparin including its comparative...
7.
King A, Higgins L, Au C, Malakouti S, Music E, Kalchthaler K, et al.
AMIA Jt Summits Transl Sci Proc
. 2024 Jun;
2024:276-284.
PMID: 38827056
Objectives: To automatically populate the case report forms (CRFs) for an international, pragmatic, multifactorial, response-adaptive, Bayesian COVID-19 platform trial. Methods: The locations of focus included 27 hospitals and 2 large...
8.
Saraiva I, Hamahata N, Huang D, Kane-Gill S, Rivosecchi R, Shiva S, et al.
BMJ Open
. 2024 Apr;
14(4):e081120.
PMID: 38688665
Introduction: Acute kidney injury (AKI) is a common complication of sepsis associated with increased risk of death. Preclinical data and observational human studies suggest that activation of AMP-activated protein kinase,...
9.
DeMerle K, Kennedy J, Chang C, Delucchi K, Huang D, Kravitz M, et al.
Sci Rep
. 2024 Mar;
14(1):6234.
PMID: 38485953
Sepsis is a heterogeneous syndrome and phenotypes have been proposed using clinical data. Less is known about the contribution of protein biomarkers to clinical sepsis phenotypes and their importance for...
10.
Bjelic M, Goldenberg I, Younis A, Chen A, Huang D, Yoruk A, et al.
J Am Heart Assoc
. 2024 Jan;
13(3):e028902.
PMID: 38240206
Background: Sex-specific risk management may improve outcomes in congenital long QT syndrome (LQTS). We recently developed a prediction score for cardiac events (CEs) and life-threatening events (LTEs) in postadolescent women...